Select for export Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s0033291723001411 PubMed 37264950 Copy citation Copy BibTeX Psychological Medicine 2023-06-01 Paul McCrone, Henry Fisher, Clare Knight, Rebecca Harding, Anne Katrin Schlag, David Nutt OpenAlex Published psilocybin DepressionChronic PainToxicity Other More
Select for export Cardiac Arrest Associated With Psilocybin Use and Hereditary Hemochromatosis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.38669 PubMed 37288212 Copy citation Copy BibTeX Cureus 2023-05-06 Suhwoo Bae, Michael Vaysblat, Edward Jong Bae, Ilja Dejanovic, Matthew Pierce OpenAlex Published psilocybin Brain ImagingPharmacologyReceptor Pharmacology Other More
Select for export Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/bmjopen-2022-068884 PubMed 37142308 Copy citation Copy BibTeX BMJ Open 2023-04-30 Alan K. Davis, Adam W. Levin, Paul Nagib, Stacey B. Armstrong, Rafael Lancelotta OpenAlex Published psilocybin AnxietyPTSDChronic Pain Clinical Trial More
Select for export A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.psycr.2023.100118 Copy citation Copy BibTeX Psychiatry Research Case Reports 2023-04-25 Eric N. Kramer, Kalyn Reddy, Bryan Shapiro OpenAlex Published psilocybin DepressionAnxietyAddiction Other More
Select for export The Canadian Psychedelic Survey: Characteristics, Patterns of Use, and Access in a Large Sample of People Who Use Psychedelic Drugs Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2023.0002 PubMed 40046727 Copy citation Copy BibTeX Psychedelic Medicine 2023-04-18 Stephanie Lake, Philippe Lucas OpenAlex Published psilocybin WellbeingObservational StudyToxicity Observational Study More
Select for export Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231154852 PubMed 36938991 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-03-19 Jordan Sloshower, Patrick D. Skosnik, Hamideh Safi-Aghdam, Surbhi Pathania, Shariful A. Syed, Brian Pittman OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020 Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231158245 PubMed 36876583 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-03-05 Emma I Kopra, Jason Ferris, Adam Winstock, Kim P. C. Kuypers, Allan H. Young, James Rucker OpenAlex Published psilocybin PTSDChronic PainReceptor Pharmacology Observational Study More
Select for export The Effects of Serotonergic Psychedelics on Neural Activity: A Meta-Analysis of Task-Based Functional Neuroimaging Studies Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/j.eurpsy.2023.1948 Copy citation Copy BibTeX European Psychiatry 2023-02-28 J. H. Shepherd, C.T.M. Baten, A. C. Klassen, G. Zamora, Sarah Saravia, Elizabeth Pritchard OpenAlex Published psilocybin Brain ImagingReceptor PharmacologyAging Meta-Analysis More
Select for export A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2022.0012 PubMed 40047006 Copy citation Copy BibTeX Psychedelic Medicine 2023-02-28 Meghan Hibicke, Hannah M. Kramer, Charles D. Nichols OpenAlex Published psilocybin DepressionNeuroplasticityPharmacology Clinical Trial More
Select for export Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jad.2023.01.108 PubMed 36740140 Copy citation Copy BibTeX Journal of Affective Disorders 2023-02-02 Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Merve Atli, James Bennett, Megan Croal OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export The association between naturalistic use of psychedelics and co-occurring substance use disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.1066369 PubMed 36704738 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-01-09 Jonina Rabinowitz, Shaul Lev-Ran, Raz Gross OpenAlex Published psilocybin AddictionClinical TrialObservational Study Clinical Trial More
Select for export Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/cns.14054 PubMed 36627756 Copy citation Copy BibTeX CNS Neuroscience & Therapeutics 2023-01-09 Jing Wang, Min Liang, Qing Shang, Hongyan Qian, Ran An, Hua Liu OpenAlex Published psilocybinpsilocin PharmacologyMechanism of ActionReceptor Pharmacology Animal Study More
Select for export A roadmap for psychedelic pharmacy in Canada: A proposed policy and operations approach for controlled access to select psychedelics for treatment of mental illness Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20503245231170340 Copy citation Copy BibTeX Drug Science Policy and Law 2022-12-31 Jaden Brandt OpenAlex Published psilocybin Toxicity Other More
Select for export From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia No abstract availability was recorded for this entry. Details DOI 10.1177/20503245231198472 Copy citation Copy BibTeX Drug Science Policy and Law 2022-12-31 Octavian Dixon Ritchie, Cameron N Donley, Gabrielle Dixon Ritchie OpenAlex Published psilocybin Toxicity Other More
Select for export Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221140004 PubMed 36588452 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-12-31 Jack E. Henningfield, Judy Ashworth, David J. Heal, Sharon L. Smith OpenAlex Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221146356 PubMed 36601974 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-12-31 Matthias Forstmann, Hannes Kettner, Christina Sagioglou, Alexander Irvine, Sam Gandy, Robin Carhart-Harris OpenAlex Published psilocybin AddictionPharmacologyToxicity Other More
Select for export Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-022-25658-5 PubMed 36535992 Copy citation Copy BibTeX Scientific Reports 2022-12-18 Grant Jones, Diego Arias, Matthew K. Nock OpenAlex Published psilocybin Observational StudyAdolescentsToxicity Observational Study More
Select for export “A sense of the bigger picture:” A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0279073 PubMed 36516137 Copy citation Copy BibTeX PLoS ONE 2022-12-13 Meghan DellaCrosse, Mollie Pleet, Emma Morton, Amir Ashtari, Kimberly Sakai, Josh Woolley OpenAlex Published psilocybin DepressionAddictionEmotional Processing Clinical Trial More
Select for export Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221131997 PubMed 36515370 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-12-13 Emma Morton, Kimberly Sakai, Amir Ashtari, Mollie Pleet, Erin E. Michalak, Josh Woolley OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients No abstract availability was recorded for this entry. Details DOI 10.1016/j.jad.2022.11.046 PubMed 36513161 Copy citation Copy BibTeX Journal of Affective Disorders 2022-12-09 Sarah Shnayder, Rezvan Ameli, Ninet Sinaii, Ann Berger, Manish Agrawal OpenAlex Published psilocybin Chronic PainWellbeingSpirituality Other More
